Literature DB >> 1975472

Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction.

D E Vaughan1, G A Lamas, M A Pfeffer.   

Abstract

Neurohumoral activation is readily apparent in patients with symptomatic congestive heart failure (CHF) and in the acute phase after acute myocardial infarction. In this study, the neurohumoral profiles of 36 asymptomatic patients in the early convalescent phase after acute myocardial infarction were examined. All patients in the study had a radionuclide ejection fraction less than or equal to 45% and underwent cardiac catheterization 11 to 30 days after infarction. Venous blood samples were obtained in the supine state for the measurement of norepinephrine, angiotensin II, plasma renin activity and aldosterone in all patients. Despite the reduced ejection fraction and extensive wall motion abnormalities, plasma norepinephrine was not elevated and did not correlate with any measured hemodynamic, angiographic or clinical variables. The renin-angiotensin II aldosterone system was activated, as expected, in the 9 study patients receiving loop diuretics. However, even in the 27 patients not taking diuretics, plasma angiotensin II and renin activity levels were increased in relation to Killip classification, the presence of a left ventricular (LV) aneurysm and LV ejection fraction. Activation of the renin-angiotensin-aldosterone system can be identified in hemodynamically compensated postinfarction patients not taking diuretics and appears to be related to the extent of LV dysfunction.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1975472     DOI: 10.1016/0002-9149(90)90476-h

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  7 in total

1.  beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study.

Authors:  K S Spargias; A S Hall; D C Greenwood; S G Ball
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

Review 2.  Neuroendocrine activation after myocardial infarction: causes and consequences.

Authors:  J G Cleland; P J Cowburn; K Morgan
Journal:  Heart       Date:  1996-11       Impact factor: 5.994

Review 3.  Neuroendocrine excitation in heart failure.

Authors:  A J Riegger
Journal:  Br Heart J       Date:  1994-08

Review 4.  Neuroendocrine activation after myocardial infarction.

Authors:  J Remes
Journal:  Br Heart J       Date:  1994-09

Review 5.  Post-myocardial infarction ventricular remodeling: animal and human studies.

Authors:  D E Vaughan; M A Pfeffer
Journal:  Cardiovasc Drugs Ther       Date:  1994-06       Impact factor: 3.727

Review 6.  Aldosterone and aldosterone antagonism in systemic hypertension.

Authors:  William H Frishman; Charles T Stier
Journal:  Curr Hypertens Rep       Date:  2004-06       Impact factor: 5.369

7.  Baroreflex sensitivity and neurohormonal activation in patients with acute myocardial infarction.

Authors:  J Hartikainen; F Fyhrquist; K Tahvanainen; E Länsimies; K Pyörälä
Journal:  Br Heart J       Date:  1995-07
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.